Immunologic therapy for hemolytic-uremic syndrome
David V. Milford(Birmingham Children's Hospital), Bernard Rowe, Carol M. Taylor(Birmingham Children's Hospital), Tom C. F. Roy(Scottish National Blood Transfusion Service), Peter Rose(Academy of Nutrition and Dietetics)
Cited by 11
Related Papers
Hydrogen Sulfide and Cell Signaling
|The Annual Review of Pharmacology and Toxicology|2011|1.3k
Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III
|Nature Genetics|1997|869
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
|British Journal of Haematology|2012|867
Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure
|Nature Genetics|2001|538
Bioactive S-alk(en)yl cysteine sulfoxide metabolites in the genus Allium: the chemistry of potential therapeutic agents
|Natural Product Reports|2005|469